Community Health (CYH) Gets a Buy Rating from Oppenheimer

By Carrie Williams

In a report released yesterday, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Community Health (CYHResearch Report), with a price target of $8.00. The company’s shares closed last Tuesday at $3.68.

According to, Wiederhorn is a top 100 analyst with an average return of 15.3% and a 67.2% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as The Ensign Group, Addus Homecare, and HCA Healthcare.

Currently, the analyst consensus on Community Health is a Moderate Sell with an average price target of $3.67.

See today’s analyst top recommended stocks >>

Based on Community Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.29 billion and GAAP net loss of $373 million. In comparison, last year the company earned revenue of $3.45 billion and had a GAAP net loss of $328 million.

Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CYH in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Community Health Systems, Inc. engages in the management and operations of hospitals. It operates general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services. The company was founded in March 1985 and is headquartered in Franklin, TN.